Xenogeneic	JJ	B-NP	O	Other	Other	###	1	Xenogeneic	Xenogeneic	JJ	JJ	_	3	amod	_	_
human	JJ	I-NP	O	Other	Other	###	2	human	human	JJ	JJ	_	3	amod	_	_
serum	NN	I-NP	O	Other	Other	###	3	serum	serum	NN	NN	_	4	nsubj	_	_
promotes	VBZ	B-VP	O	Other	Other	###	4	promotes	promotes	VBZ	VBZ	_	0	root	_	_
leukocyte	NN	B-NP	O	Other	Other	###	5	leukocyte	leukocyte	NN	NN	_	6	compound	_	_
adhesion	NN	I-NP	O	Other	Other	###	6	adhesion	adhesion	NN	NN	_	4	dobj	_	_
to	TO	B-PP	O	Other	Other	###	7	to	to	TO	TO	_	9	case	_	_
porcine	JJ	B-NP	O	Other	Other	###	8	porcine	porcine	JJ	JJ	_	9	amod	_	_
endothelium	NN	I-NP	O	Other	Other	###	9	endothelium	endothelium	NN	NN	_	6	nmod	_	_
under	IN	B-PP	O	Other	Other	###	10	under	under	IN	IN	_	12	case	_	_
flow	NN	B-NP	O	Other	Other	###	11	flow	flow	NN	NN	_	12	compound	_	_
conditions	NNS	I-NP	O	Other	Other	###	12	conditions	conditions	NNS	NNS	_	4	nmod	_	_
,	,	O	O	Other	Other	###	13	,	,	,	,	_	4	punct	_	_
possibly	RB	B-ADVP	O	Other	Other	###	14	possibly	possibly	RB	RB	_	17	advmod	_	_
through	IN	B-PP	O	Other	Other	###	15	through	through	IN	IN	_	17	case	_	_
the	DT	B-NP	O	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
activation	NN	I-NP	O	Other	Other	###	17	activation	activation	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	Other	###	18	of	of	IN	IN	_	23	case	_	_
the	DT	B-NP	O	Other	Other	###	19	the	the	DT	DT	_	23	det	_	_
transcription	NN	I-NP	B-protein	Other	Other	###	20	transcription	transcription	NN	NN	_	23	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	###	21	factor	factor	NN	NN	_	23	compound	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	###	22	NF-kappa	NF-kappa	NN	NN	_	23	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	23	B	B	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	Other	###	24	.	.	.	.	_	4	punct	_	_

Endothelial	JJ	B-NP	B-cell_type	Other	Other	###	1	Endothelial	Endothelial	JJ	JJ	_	3	amod	_	_
cell	NN	I-NP	I-cell_type	Other	Other	###	2	cell	cell	NN	NN	_	3	compound	_	_
activation	NN	I-NP	O	Other	Other	###	3	activation	activation	NN	NN	_	10	nsubj	_	_
and	CC	O	O	Other	Other	###	4	and	and	CC	CC	_	3	cc	_	_
leukocyte	NN	B-NP	O	Other	Other	###	5	leukocyte	leukocyte	NN	NN	_	6	compound	_	_
infiltration	NN	I-NP	O	Other	Other	###	6	infiltration	infiltration	NN	NN	_	3	conj	_	_
are	VBP	B-VP	O	Other	Other	###	7	are	are	VBP	VBP	_	10	cop	_	_
a	DT	B-NP	O	Other	Other	###	8	a	a	DT	DT	_	10	det	_	_
consistent	JJ	I-NP	O	Other	Other	###	9	consistent	consistent	JJ	JJ	_	10	amod	_	_
feature	NN	I-NP	O	Other	Other	###	10	feature	feature	NN	NN	_	0	root	_	_
of	IN	B-PP	O	Other	Other	###	11	of	of	IN	IN	_	14	case	_	_
discordant	JJ	B-NP	O	Other	Other	###	12	discordant	discordant	JJ	JJ	_	14	amod	_	_
xenograft	NN	I-NP	O	Other	Other	###	13	xenograft	xenograft	NN	NN	_	14	compound	_	_
rejection	NN	I-NP	O	Other	Other	###	14	rejection	rejection	NN	NN	_	10	nmod	_	_
.	.	O	O	Other	Other	###	15	.	.	.	.	_	10	punct	_	_

Here	RB	B-ADVP	O	Other	Other	###	1	Here	Here	RB	RB	_	3	advmod	_	_
we	PRP	B-NP	O	Other	Other	###	2	we	we	PRP	PRP	_	3	nsubj	_	_
evaluated	VBD	B-VP	O	Other	Other	###	3	evaluated	evaluated	VBD	VBD	_	0	root	_	_
whether	IN	B-SBAR	O	Other	Other	###	4	whether	whether	IN	IN	_	18	mark	_	_
xenogeneic	JJ	B-NP	O	Other	Other	###	5	xenogeneic	xenogeneic	JJ	JJ	_	6	amod	_	_
serum	NN	I-NP	O	Other	Other	###	6	serum	serum	NN	NN	_	18	nsubj	_	_
,	,	O	O	Other	Other	###	7	,	,	,	,	_	6	punct	_	_
as	IN	B-PP	O	Other	Other	###	8	as	as	IN	IN	_	10	case	_	_
a	DT	B-NP	O	Other	Other	###	9	a	a	DT	DT	_	10	det	_	_
source	NN	I-NP	O	Other	Other	###	10	source	source	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	Other	###	11	of	of	IN	IN	_	14	case	_	_
xenoreactive	JJ	B-NP	B-protein	Other	Other	###	12	xenoreactive	xenoreactive	JJ	JJ	_	14	amod	_	_
natural	JJ	I-NP	I-protein	Other	Other	###	13	natural	natural	JJ	JJ	_	14	amod	_	_
antibodies	NNS	I-NP	I-protein	Other	Other	###	14	antibodies	antibodies	NNS	NNS	_	10	nmod	_	_
and	CC	O	O	Other	Other	###	15	and	and	CC	CC	_	14	cc	_	_
complement	NN	B-NP	O	Other	Other	###	16	complement	complement	NN	NN	_	14	conj	_	_
,	,	O	O	Other	Other	###	17	,	,	,	,	_	6	punct	_	_
induced	VBD	B-VP	O	Other	Other	###	18	induced	induced	VBD	VBD	_	3	ccomp	_	_
endothelial	JJ	B-NP	B-cell_type	Other	Other	###	19	endothelial	endothelial	JJ	JJ	_	21	amod	_	_
cell	NN	I-NP	I-cell_type	Other	Other	###	20	cell	cell	NN	NN	_	21	compound	_	_
activation	NN	I-NP	O	Other	Other	###	21	activation	activation	NN	NN	_	18	dobj	_	_
with	IN	B-PP	O	Other	Other	###	22	with	with	IN	IN	_	25	case	_	_
consequent	JJ	B-NP	O	Other	Other	###	23	consequent	consequent	JJ	JJ	_	25	amod	_	_
leukocyte	NN	I-NP	O	Other	Other	###	24	leukocyte	leukocyte	NN	NN	_	25	compound	_	_
adhesion	NN	I-NP	O	Other	Other	###	25	adhesion	adhesion	NN	NN	_	18	nmod	_	_
under	IN	B-PP	O	Other	Other	###	26	under	under	IN	IN	_	28	case	_	_
flow	NN	B-NP	O	Other	Other	###	27	flow	flow	NN	NN	_	28	compound	_	_
conditions	NNS	I-NP	O	Other	Other	###	28	conditions	conditions	NNS	NNS	_	25	nmod	_	_
.	.	O	O	Other	Other	###	29	.	.	.	.	_	3	punct	_	_

Porcine	JJ	B-NP	B-cell_line	Other	Other	###	1	Porcine	Porcine	JJ	JJ	_	4	amod	_	_
aortic	JJ	I-NP	I-cell_line	Other	Other	###	2	aortic	aortic	JJ	JJ	_	4	amod	_	_
endothelial	JJ	I-NP	I-cell_line	Other	Other	###	3	endothelial	endothelial	JJ	JJ	_	4	amod	_	_
cells	NNS	I-NP	I-cell_line	Other	Other	###	4	cells	cells	NNS	NNS	_	9	nsubjpass	_	_
(	(	O	O	Other	Other	###	5	(	(	(	(	_	6	punct	_	_
PAEC	NNS	B-NP	B-cell_line	Other	Other	###	6	PAEC	PAEC	NNS	NNS	_	4	appos	_	_
)	)	O	O	Other	Other	###	7	)	)	)	)	_	6	punct	_	_
were	VBD	B-VP	O	Other	Other	###	8	were	were	VBD	VBD	_	9	auxpass	_	_
incubated	VBN	I-VP	O	Other	Other	###	9	incubated	incubated	VBN	VBN	_	0	root	_	_
for	IN	B-PP	O	Other	Other	###	10	for	for	IN	IN	_	12	case	_	_
1	CD	B-NP	O	Other	Other	###	11	1	1	CD	CD	_	12	nummod	_	_
hr	NN	I-NP	O	Other	Other	###	12	hr	hr	NN	NN	_	9	nmod	_	_
30	CD	B-NP	O	Other	Other	###	13	30	30	CD	CD	_	14	nummod	_	_
min	NN	I-NP	O	Other	Other	###	14	min	min	NN	NN	_	9	nmod	_	_
or	CC	O	O	Other	Other	###	15	or	or	CC	CC	_	14	cc	_	_
5	CD	B-NP	O	Other	Other	###	16	5	5	CD	CD	_	17	nummod	_	_
hr	NN	I-NP	O	Other	Other	###	17	hr	hr	NN	NN	_	14	conj	_	_
with	IN	B-PP	O	Other	Other	###	18	with	with	IN	IN	_	23	case	_	_
10	CD	B-NP	O	Other	Other	###	19	10	10	CD	CD	_	20	compound	_	_
%	NN	I-NP	O	Other	Other	###	20	%	%	NN	NN	_	23	amod	_	_
homologous	JJ	I-NP	O	Other	Other	###	21	homologous	homologous	JJ	JJ	_	23	amod	_	_
porcine	JJ	I-NP	O	Other	Other	###	22	porcine	porcine	JJ	JJ	_	23	amod	_	_
serum	NN	I-NP	O	Other	Other	###	23	serum	serum	NN	NN	_	9	nmod	_	_
(	(	O	O	Other	Other	###	24	(	(	(	(	_	25	punct	_	_
control	NN	B-NP	O	Other	Other	###	25	control	control	NN	NN	_	23	appos	_	_
)	)	O	O	Other	Other	###	26	)	)	)	)	_	25	punct	_	_
or	CC	O	O	Other	Other	###	27	or	or	CC	CC	_	23	cc	_	_
10	CD	B-NP	O	Other	Other	###	28	10	10	CD	CD	_	29	compound	_	_
%	NN	I-NP	O	Other	Other	###	29	%	%	NN	NN	_	32	amod	_	_
xenogeneic	JJ	I-NP	O	Other	Other	###	30	xenogeneic	xenogeneic	JJ	JJ	_	32	amod	_	_
human	JJ	I-NP	O	Other	Other	###	31	human	human	JJ	JJ	_	32	amod	_	_
serum	NN	I-NP	O	Other	Other	###	32	serum	serum	NN	NN	_	23	conj	_	_
and	CC	O	O	Other	Other	###	33	and	and	CC	CC	_	9	cc	_	_
then	RB	B-VP	O	Other	Other	###	34	then	then	RB	RB	_	9	advmod	_	_
perfused	VBN	I-VP	O	Other	Other	###	35	perfused	perfused	VBN	VBN	_	9	conj	_	_
with	IN	B-PP	O	Other	Other	###	36	with	with	IN	IN	_	39	case	_	_
total	JJ	B-NP	O	Other	Other	###	37	total	total	JJ	JJ	_	39	amod	_	_
human	JJ	I-NP	B-cell_type	Other	Other	###	38	human	human	JJ	JJ	_	39	amod	_	_
leukocytes	NNS	I-NP	I-cell_type	Other	Other	###	39	leukocytes	leukocytes	NNS	NNS	_	35	nmod	_	_
in	IN	B-PP	O	Other	Other	###	40	in	in	IN	IN	_	45	case	_	_
a	DT	B-NP	O	Other	Other	###	41	a	a	DT	DT	_	45	det	_	_
parallel	JJ	I-NP	O	Other	Other	###	42	parallel	parallel	JJ	JJ	_	45	amod	_	_
plate	NN	I-NP	O	Other	Other	###	43	plate	plate	NN	NN	_	45	compound	_	_
flow	NN	I-NP	O	Other	Other	###	44	flow	flow	NN	NN	_	45	compound	_	_
chamber	NN	I-NP	O	Other	Other	###	45	chamber	chamber	NN	NN	_	35	nmod	_	_
under	IN	B-PP	O	Other	Other	###	46	under	under	IN	IN	_	48	case	_	_
laminar	JJ	B-NP	O	Other	Other	###	47	laminar	laminar	JJ	JJ	_	48	amod	_	_
flow	NN	I-NP	O	Other	Other	###	48	flow	flow	NN	NN	_	45	nmod	_	_
(	(	O	O	Other	Other	###	49	(	(	(	(	_	51	punct	_	_
1.5	CD	B-NP	O	Other	Other	###	50	1.5	1.5	CD	CD	_	51	nummod	_	_
dynes	NN	I-NP	O	Other	Other	###	51	dynes	dynes	NN	NN	_	45	dep	_	_
/	/	O	O	Other	Other	###	52	/	/	/	/	_	51	punct	_	_
cm2	NN	I-NP	O	Other	Other	###	53	cm2	cm2	NN	NN	_	51	appos	_	_
)	)	O	O	Other	Other	###	54	)	)	)	)	_	51	punct	_	_
.	.	O	O	Other	Other	###	55	.	.	.	.	_	9	punct	_	_

Adherent	JJ	B-NP	B-cell_type	Other	Other	###	1	Adherent	Adherent	JJ	JJ	_	2	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	2	cells	cells	NNS	NNS	_	4	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	###	3	were	were	VBD	VBD	_	4	auxpass	_	_
counted	VBN	I-VP	O	Other	Other	###	4	counted	counted	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	Other	###	5	by	by	IN	IN	_	8	case	_	_
digital	JJ	B-NP	O	Other	Other	###	6	digital	digital	JJ	JJ	_	8	amod	_	_
image	NN	I-NP	O	Other	Other	###	7	image	image	NN	NN	_	8	compound	_	_
analysis	NN	I-NP	O	Other	Other	###	8	analysis	analysis	NN	NN	_	4	nmod	_	_
.	.	O	O	Other	Other	###	9	.	.	.	.	_	4	punct	_	_

Xenogeneic	JJ	B-NP	O	Other	Other	###	1	Xenogeneic	Xenogeneic	JJ	JJ	_	3	amod	_	_
human	JJ	I-NP	O	Other	Other	###	2	human	human	JJ	JJ	_	3	amod	_	_
serum	NN	I-NP	O	Other	Other	###	3	serum	serum	NN	NN	_	10	nsubj	_	_
significantly	RB	B-ADVP	O	Other	Other	###	4	significantly	significantly	RB	RB	_	10	advmod	_	_
(	(	O	O	Other	Other	###	5	(	(	(	(	_	8	punct	_	_
P	NN	B-NP	O	Other	Other	###	6	P	P	NN	NN	_	8	nsubj	_	_
<	SYM	O	O	Other	Other	###	7	<	<	SYM	SYM	_	8	dep	_	_
0.01	CD	B-NP	O	Other	Other	###	8	0.01	0.01	CD	CD	_	3	appos	_	_
)	)	O	O	Other	Other	###	9	)	)	)	)	_	8	punct	_	_
increased	VBD	B-VP	O	Other	Other	###	10	increased	increased	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	Other	###	11	the	the	DT	DT	_	12	det	_	_
number	NN	I-NP	O	Other	Other	###	12	number	number	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	Other	###	13	of	of	IN	IN	_	15	case	_	_
adherent	JJ	B-NP	B-cell_type	Other	Other	###	14	adherent	adherent	JJ	JJ	_	15	amod	_	_
leukocytes	NNS	I-NP	I-cell_type	Other	Other	###	15	leukocytes	leukocytes	NNS	NNS	_	12	nmod	_	_
as	IN	B-PP	O	Other	Other	###	16	as	as	IN	IN	_	17	mark	_	_
compared	VBN	B-PP	O	Other	Other	###	17	compared	compared	VBN	VBN	_	10	advcl	_	_
with	IN	B-PP	O	Other	Other	###	18	with	with	IN	IN	_	20	case	_	_
porcine	JJ	B-NP	O	Other	Other	###	19	porcine	porcine	JJ	JJ	_	20	amod	_	_
serum	NN	I-NP	O	Other	Other	###	20	serum	serum	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	Other	###	21	.	.	.	.	_	10	punct	_	_

A	DT	B-NP	O	Other	Other	###	1	A	A	DT	DT	_	4	det	_	_
similar	JJ	I-NP	O	Other	Other	###	2	similar	similar	JJ	JJ	_	4	amod	_	_
adhesive	JJ	I-NP	O	Other	Other	###	3	adhesive	adhesive	JJ	JJ	_	4	amod	_	_
response	NN	I-NP	O	Other	Other	###	4	response	response	NN	NN	_	6	nsubjpass	_	_
was	VBD	B-VP	O	Other	Other	###	5	was	was	VBD	VBD	_	6	auxpass	_	_
elicited	VBN	I-VP	O	Other	Other	###	6	elicited	elicited	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	Other	###	7	by	by	IN	IN	_	9	case	_	_
TNF	NN	B-NP	B-protein	Other	Other	###	8	TNF	TNF	NN	NN	_	9	compound	_	_
alpha	NN	I-NP	I-protein	Other	Other	###	9	alpha	alpha	NN	NN	_	6	nmod	_	_
(	(	O	O	Other	Other	###	10	(	(	(	(	_	12	punct	_	_
100	CD	B-NP	O	Other	Other	###	11	100	100	CD	CD	_	12	nummod	_	_
U	NN	I-NP	O	Other	Other	###	12	U	U	NN	NN	_	9	dep	_	_
/	/	O	O	Other	Other	###	13	/	/	/	/	_	14	punct	_	_
ml	NN	I-NP	O	Other	Other	###	14	ml	ml	NN	NN	_	12	appos	_	_
)	)	O	O	Other	Other	###	15	)	)	)	)	_	14	punct	_	_
,	,	O	O	Other	Other	###	16	,	,	,	,	_	9	punct	_	_
one	CD	B-NP	O	Other	Other	###	17	one	one	CD	CD	_	9	appos	_	_
of	IN	B-PP	O	Other	Other	###	18	of	of	IN	IN	_	22	case	_	_
the	DT	B-NP	O	Other	Other	###	19	the	the	DT	DT	_	22	det	_	_
most	RBS	I-NP	O	Other	Other	###	20	most	most	RBS	RBS	_	21	advmod	_	_
potent	JJ	I-NP	O	Other	Other	###	21	potent	potent	JJ	JJ	_	22	amod	_	_
inducers	NNS	I-NP	O	Other	Other	###	22	inducers	inducers	NNS	NNS	_	17	nmod	_	_
of	IN	B-PP	O	Other	Other	###	23	of	of	IN	IN	_	27	case	_	_
endothelial	JJ	B-NP	B-cell_type	Other	Other	###	24	endothelial	endothelial	JJ	JJ	_	27	amod	_	_
cell	NN	I-NP	I-cell_type	Other	Other	###	25	cell	cell	NN	NN	_	27	compound	_	_
adhesive	JJ	I-NP	O	Other	Other	###	26	adhesive	adhesive	JJ	JJ	_	27	amod	_	_
properties	NNS	I-NP	O	Other	Other	###	27	properties	properties	NNS	NNS	_	22	nmod	_	_
,	,	O	O	Other	Other	###	28	,	,	,	,	_	22	punct	_	_
here	RB	B-ADVP	O	Other	Other	###	29	here	here	RB	RB	_	30	advmod	_	_
used	VBN	B-VP	O	Other	Other	###	30	used	used	VBN	VBN	_	22	acl	_	_
as	IN	B-PP	O	Other	Other	###	31	as	as	IN	IN	_	33	case	_	_
positive	JJ	B-NP	O	Other	Other	###	32	positive	positive	JJ	JJ	_	33	amod	_	_
control	NN	I-NP	O	Other	Other	###	33	control	control	NN	NN	_	30	nmod	_	_
.	.	O	O	Other	Other	###	34	.	.	.	.	_	6	punct	_	_

In	IN	B-SBAR	O	Other	Other	###	1	In	In	IN	IN	_	4	mark	_	_
order	NN	O	O	Other	Other	###	2	order	order	NN	NN	_	1	mwe	_	_
to	TO	B-VP	O	Other	Other	###	3	to	to	TO	TO	_	4	dep	_	_
elucidate	VB	I-VP	O	Other	Other	###	4	elucidate	elucidate	VB	VB	_	16	advcl	_	_
possible	JJ	B-NP	O	Other	Other	###	5	possible	possible	JJ	JJ	_	6	amod	_	_
mechanisms	NNS	I-NP	O	Other	Other	###	6	mechanisms	mechanisms	NNS	NNS	_	4	dobj	_	_
underlying	VBG	B-VP	O	Other	Other	###	7	underlying	underlying	VBG	VBG	_	6	acl	_	_
endothelial	JJ	B-NP	B-cell_type	Other	Other	###	8	endothelial	endothelial	JJ	JJ	_	10	amod	_	_
cell	NN	I-NP	I-cell_type	Other	Other	###	9	cell	cell	NN	NN	_	10	compound	_	_
activation	NN	I-NP	O	Other	Other	###	10	activation	activation	NN	NN	_	7	dobj	_	_
by	IN	B-PP	O	Other	Other	###	11	by	by	IN	IN	_	13	case	_	_
xenogeneic	JJ	B-NP	O	Other	Other	###	12	xenogeneic	xenogeneic	JJ	JJ	_	13	amod	_	_
serum	NN	I-NP	O	Other	Other	###	13	serum	serum	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	Other	###	14	,	,	,	,	_	16	punct	_	_
we	PRP	B-NP	O	Other	Other	###	15	we	we	PRP	PRP	_	16	nsubj	_	_
focussed	VBD	B-VP	O	Other	Other	###	16	focussed	focussed	VBD	VBD	_	0	root	_	_
on	IN	B-PP	O	Other	Other	###	17	on	on	IN	IN	_	21	case	_	_
transcription	NN	B-NP	B-protein	Other	Other	###	18	transcription	transcription	NN	NN	_	21	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	###	19	factor	factor	NN	NN	_	21	compound	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	###	20	NF-kappa	NF-kappa	NN	NN	_	21	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	21	B	B	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	Other	###	22	,	,	,	,	_	21	punct	_	_
a	DT	B-NP	O	Other	Other	###	23	a	a	DT	DT	_	25	det	_	_
central	JJ	I-NP	O	Other	Other	###	24	central	central	JJ	JJ	_	25	amod	_	_
regulator	NN	I-NP	O	Other	Other	###	25	regulator	regulator	NN	NN	_	21	appos	_	_
for	IN	B-PP	O	Other	Other	###	26	for	for	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	Other	###	27	the	the	DT	DT	_	28	det	_	_
induction	NN	I-NP	O	Other	Other	###	28	induction	induction	NN	NN	_	25	nmod	_	_
of	IN	B-PP	O	Other	Other	###	29	of	of	IN	IN	_	31	case	_	_
different	JJ	B-NP	O	Other	Other	###	30	different	different	JJ	JJ	_	31	amod	_	_
genes	NNS	I-NP	O	Other	Other	###	31	genes	genes	NNS	NNS	_	28	nmod	_	_
,	,	O	O	Other	Other	###	32	,	,	,	,	_	31	punct	_	_
including	VBG	B-PP	O	Other	Other	###	33	including	including	VBG	VBG	_	35	case	_	_
adhesive	JJ	B-NP	B-protein	Other	Other	###	34	adhesive	adhesive	JJ	JJ	_	35	amod	_	_
molecules	NNS	I-NP	I-protein	Other	Other	###	35	molecules	molecules	NNS	NNS	_	31	nmod	_	_
and	CC	I-NP	O	Other	Other	###	36	and	and	CC	CC	_	35	cc	_	_
chemoattractants	NNS	I-NP	B-protein	Other	Other	###	37	chemoattractants	chemoattractants	NNS	NNS	_	35	conj	_	_
.	.	O	O	Other	Other	###	38	.	.	.	.	_	16	punct	_	_

By	IN	B-PP	O	Other	Other	###	1	By	By	IN	IN	_	4	case	_	_
confocal	JJ	B-NP	O	Other	Other	###	2	confocal	confocal	JJ	JJ	_	4	amod	_	_
fluorescence	NN	I-NP	O	Other	Other	###	3	fluorescence	fluorescence	NN	NN	_	4	compound	_	_
microscopy	NN	I-NP	O	Other	Other	###	4	microscopy	microscopy	NN	NN	_	7	nmod	_	_
,	,	O	O	Other	Other	###	5	,	,	,	,	_	7	punct	_	_
we	PRP	B-NP	O	Other	Other	###	6	we	we	PRP	PRP	_	7	nsubj	_	_
observed	VBD	B-VP	O	Other	Other	###	7	observed	observed	VBD	VBD	_	0	root	_	_
a	DT	B-NP	O	Other	Other	###	8	a	a	DT	DT	_	10	det	_	_
positive	JJ	I-NP	O	Other	Other	###	9	positive	positive	JJ	JJ	_	10	amod	_	_
staining	NN	I-NP	O	Other	Other	###	10	staining	staining	NN	NN	_	7	dobj	_	_
for	IN	B-PP	O	Other	Other	###	11	for	for	IN	IN	_	13	case	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	###	12	NF-kappa	NF-kappa	NN	NN	_	13	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	13	B	B	NN	NN	_	10	nmod	_	_
(	(	O	O	Other	Other	###	14	(	(	(	(	_	16	punct	_	_
p65	NN	B-NP	B-protein	B-Protein	Other	###	15	p65	p65	NN	NN	_	16	compound	_	_
subunit	NN	I-NP	I-protein	Other	Other	###	16	subunit	subunit	NN	NN	_	13	appos	_	_
)	)	O	O	Other	Other	###	17	)	)	)	)	_	16	punct	_	_
in	IN	B-PP	O	Other	Other	###	18	in	in	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	Other	###	19	the	the	DT	DT	_	20	det	_	_
nuclei	NNS	I-NP	O	Other	Other	###	20	nuclei	nuclei	NNS	NNS	_	10	nmod	_	_
of	IN	B-PP	O	Other	Other	###	21	of	of	IN	IN	_	22	case	_	_
PAEC	NNS	B-NP	B-cell_line	Other	Other	###	22	PAEC	PAEC	NNS	NNS	_	20	nmod	_	_
exposed	VBN	B-VP	O	Other	Other	###	23	exposed	exposed	VBN	VBN	_	22	acl	_	_
for	IN	B-PP	O	Other	Other	###	24	for	for	IN	IN	_	28	case	_	_
1	CD	B-NP	O	Other	Other	###	25	1	1	CD	CD	_	26	nummod	_	_
hr	NN	I-NP	O	Other	Other	###	26	hr	hr	NN	NN	_	23	nmod	_	_
30	CD	B-NP	O	Other	Other	###	27	30	30	CD	CD	_	28	nummod	_	_
min	NN	I-NP	O	Other	Other	###	28	min	min	NN	NN	_	23	nmod	_	_
to	TO	B-PP	O	Other	Other	###	29	to	to	TO	TO	_	31	case	_	_
human	JJ	B-NP	O	Other	Other	###	30	human	human	JJ	JJ	_	31	amod	_	_
serum	NN	I-NP	O	Other	Other	###	31	serum	serum	NN	NN	_	28	nmod	_	_
,	,	O	O	Other	Other	###	32	,	,	,	,	_	10	punct	_	_
which	WDT	B-NP	O	Other	Other	###	33	which	which	WDT	WDT	_	34	nsubj	_	_
indicated	VBD	B-VP	O	Other	Other	###	34	indicated	indicated	VBD	VBD	_	10	acl:relcl	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	###	35	NF-kappa	NF-kappa	NN	NN	_	37	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	36	B	B	NN	NN	_	37	compound	_	_
activation	NN	I-NP	O	Other	Other	###	37	activation	activation	NN	NN	_	34	dobj	_	_
in	IN	B-PP	O	Other	Other	###	38	in	in	IN	IN	_	40	case	_	_
this	DT	B-NP	O	Other	Other	###	39	this	this	DT	DT	_	40	det	_	_
setting	NN	I-NP	O	Other	Other	###	40	setting	setting	NN	NN	_	37	nmod	_	_
.	.	O	O	Other	Other	###	41	.	.	.	.	_	7	punct	_	_

At	IN	B-PP	O	Other	Other	###	1	At	At	IN	IN	_	2	case	_	_
variance	NN	B-NP	O	Other	Other	###	2	variance	variance	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	Other	###	3	,	,	,	,	_	16	punct	_	_
in	IN	B-PP	O	Other	Other	###	4	in	in	IN	IN	_	5	case	_	_
PAEC	NNS	B-NP	B-cell_line	Other	Other	###	5	PAEC	PAEC	NNS	NNS	_	16	nmod	_	_
incubated	VBN	B-VP	O	Other	Other	###	6	incubated	incubated	VBN	VBN	_	5	acl	_	_
with	IN	B-PP	O	Other	Other	###	7	with	with	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	Other	###	8	the	the	DT	DT	_	10	det	_	_
homologous	JJ	I-NP	O	Other	Other	###	9	homologous	homologous	JJ	JJ	_	10	amod	_	_
serum	NN	I-NP	O	Other	Other	###	10	serum	serum	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	Other	###	11	,	,	,	,	_	16	punct	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	###	12	NF-kappa	NF-kappa	NN	NN	_	13	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	13	B	B	NN	NN	_	16	nsubj	_	_
was	VBD	B-VP	O	Other	Other	###	14	was	was	VBD	VBD	_	16	auxpass	_	_
strictly	RB	I-VP	O	Other	Other	###	15	strictly	strictly	RB	RB	_	16	advmod	_	_
localized	VBN	I-VP	O	Other	Other	###	16	localized	localized	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	17	in	in	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	Other	###	18	the	the	DT	DT	_	20	det	_	_
cell	NN	I-NP	O	Other	Other	###	19	cell	cell	NN	NN	_	20	compound	_	_
cytoplasm	NN	I-NP	O	Other	Other	###	20	cytoplasm	cytoplasm	NN	NN	_	16	nmod	_	_
.	.	O	O	Other	Other	###	21	.	.	.	.	_	16	punct	_	_

Treatment	NN	B-NP	O	Other	Other	###	1	Treatment	Treatment	NN	NN	_	34	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	2	of	of	IN	IN	_	3	case	_	_
PAEC	NNS	B-NP	B-cell_line	Other	Other	###	3	PAEC	PAEC	NNS	NNS	_	1	nmod	_	_
exposed	VBN	B-VP	O	Other	Other	###	4	exposed	exposed	VBN	VBN	_	3	acl	_	_
to	TO	B-PP	O	Other	Other	###	5	to	to	TO	TO	_	7	case	_	_
xenogeneic	JJ	B-NP	O	Other	Other	###	6	xenogeneic	xenogeneic	JJ	JJ	_	7	amod	_	_
serum	NN	I-NP	O	Other	Other	###	7	serum	serum	NN	NN	_	4	nmod	_	_
with	IN	B-PP	O	Other	Other	###	8	with	with	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	Other	###	9	the	the	DT	DT	_	12	det	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	###	10	NF-kappa	NF-kappa	NN	NN	_	12	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	11	B	B	NN	NN	_	12	compound	_	_
inhibitors	NNS	I-NP	O	Other	Other	###	12	inhibitors	inhibitors	NNS	NNS	_	7	nmod	_	_
pyrrolidinedithiocarbamate	NN	B-NP	O	Other	Other	###	13	pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	NN	NN	_	12	dep	_	_
(	(	O	O	Other	Other	###	14	(	(	(	(	_	15	punct	_	_
PDTC	NN	B-NP	O	Other	Other	###	15	PDTC	PDTC	NN	NN	_	13	dep	_	_
,	,	O	O	Other	Other	###	16	,	,	,	,	_	15	punct	_	_
25	CD	B-NP	O	Other	Other	###	17	25	25	CD	CD	_	18	nummod	_	_
microM	NN	I-NP	O	Other	Other	###	18	microM	microM	NN	NN	_	15	appos	_	_
)	)	O	O	Other	Other	###	19	)	)	)	)	_	15	punct	_	_
and	CC	O	O	Other	Other	###	20	and	and	CC	CC	_	13	cc	_	_
tosyl-phechloromethylketone	NN	B-NP	O	Other	Other	###	21	tosyl-phechloromethylketone	tosyl-phechloromethylketone	NN	NN	_	13	conj	_	_
(	(	O	O	Other	Other	###	22	(	(	(	(	_	23	punct	_	_
TPCK	NN	B-NP	O	Other	Other	###	23	TPCK	TPCK	NN	NN	_	21	dep	_	_
,	,	O	O	Other	Other	###	24	,	,	,	,	_	23	punct	_	_
25	CD	B-NP	O	Other	Other	###	25	25	25	CD	CD	_	26	nummod	_	_
microM	NN	I-NP	O	Other	Other	###	26	microM	microM	NN	NN	_	23	appos	_	_
)	)	O	O	Other	Other	###	27	)	)	)	)	_	23	punct	_	_
significantly	RB	B-ADVP	O	Other	Other	###	28	significantly	significantly	RB	RB	_	34	advmod	_	_
(	(	O	O	Other	Other	###	29	(	(	(	(	_	32	punct	_	_
P	NN	B-NP	O	Other	Other	###	30	P	P	NN	NN	_	32	nsubj	_	_
<	SYM	O	O	Other	Other	###	31	<	<	SYM	SYM	_	32	dep	_	_
0.01	CD	B-NP	O	Other	Other	###	32	0.01	0.01	CD	CD	_	34	parataxis	_	_
)	)	O	O	Other	Other	###	33	)	)	)	)	_	32	punct	_	_
reduced	VBD	B-VP	O	Other	Other	###	34	reduced	reduced	VBD	VBD	_	0	root	_	_
leukocyte	NN	B-NP	O	Other	Other	###	35	leukocyte	leukocyte	NN	NN	_	36	compound	_	_
adhesion	NN	I-NP	O	Other	Other	###	36	adhesion	adhesion	NN	NN	_	34	dobj	_	_
in	IN	B-PP	O	Other	Other	###	37	in	in	IN	IN	_	40	case	_	_
respect	NN	B-NP	O	Other	Other	###	38	respect	respect	NN	NN	_	40	dep	_	_
to	TO	B-PP	O	Other	Other	###	39	to	to	TO	TO	_	40	case	_	_
PAEC	NNS	B-NP	B-cell_line	Other	Other	###	40	PAEC	PAEC	NNS	NNS	_	34	nmod	_	_
treated	VBN	B-VP	O	Other	Other	###	41	treated	treated	VBN	VBN	_	40	acl	_	_
with	IN	B-PP	O	Other	Other	###	42	with	with	IN	IN	_	44	case	_	_
human	JJ	B-NP	O	Other	Other	###	43	human	human	JJ	JJ	_	44	amod	_	_
serum	NN	I-NP	O	Other	Other	###	44	serum	serum	NN	NN	_	41	nmod	_	_
alone	RB	B-ADVP	O	Other	Other	###	45	alone	alone	RB	RB	_	44	advmod	_	_
.	.	O	O	Other	Other	###	46	.	.	.	.	_	34	punct	_	_

Findings	NNS	B-NP	O	Other	Other	###	1	Findings	Findings	NNS	NNS	_	15	nsubj	_	_
that	IN	B-SBAR	O	Other	Other	###	2	that	that	IN	IN	_	5	mark	_	_
xenogeneic	JJ	B-NP	O	Other	Other	###	3	xenogeneic	xenogeneic	JJ	JJ	_	4	amod	_	_
serum	NN	I-NP	O	Other	Other	###	4	serum	serum	NN	NN	_	5	nsubj	_	_
promotes	VBZ	B-VP	O	Other	Other	###	5	promotes	promotes	VBZ	VBZ	_	1	ccomp	_	_
leukocyte-endothelium	NN	B-NP	O	Other	Other	###	6	leukocyte-endothelium	leukocyte-endothelium	NN	NN	_	7	compound	_	_
interaction	NN	I-NP	O	Other	Other	###	7	interaction	interaction	NN	NN	_	5	dobj	_	_
possibly	RB	B-ADVP	O	Other	Other	###	8	possibly	possibly	RB	RB	_	12	advmod	_	_
through	IN	B-PP	O	Other	Other	###	9	through	through	IN	IN	_	12	case	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	###	10	NF-kappa	NF-kappa	NN	NN	_	11	compound	_	_
B	NN	I-NP	I-protein	Other	Other	###	11	B	B	NN	NN	_	12	compound	_	_
activation	NN	I-NP	O	Other	Other	###	12	activation	activation	NN	NN	_	5	nmod	_	_
might	MD	B-VP	O	Other	Other	###	13	might	might	MD	MD	_	15	aux	_	_
be	VB	I-VP	O	Other	Other	###	14	be	be	VB	VB	_	15	cop	_	_
relevant	JJ	B-ADJP	O	Other	Other	###	15	relevant	relevant	JJ	JJ	_	0	root	_	_
for	IN	B-PP	O	Other	Other	###	16	for	for	IN	IN	_	17	mark	_	_
designing	VBG	B-VP	O	Other	Other	###	17	designing	designing	VBG	VBG	_	15	advcl	_	_
future	JJ	B-NP	O	Other	Other	###	18	future	future	JJ	JJ	_	20	amod	_	_
therapeutic	JJ	I-NP	O	Other	Other	###	19	therapeutic	therapeutic	JJ	JJ	_	20	amod	_	_
strategies	NNS	I-NP	O	Other	Other	###	20	strategies	strategies	NNS	NNS	_	17	dobj	_	_
aimed	VBN	B-VP	O	Other	Other	###	21	aimed	aimed	VBN	VBN	_	20	acl	_	_
at	IN	B-PP	O	Other	Other	###	22	at	at	IN	IN	_	23	mark	_	_
prolonging	VBG	B-VP	O	Other	Other	###	23	prolonging	prolonging	VBG	VBG	_	21	advcl	_	_
xenograft	NN	B-NP	O	Other	Other	###	24	xenograft	xenograft	NN	NN	_	25	compound	_	_
survival	NN	I-NP	O	Other	Other	###	25	survival	survival	NN	NN	_	23	dobj	_	_
.	.	O	O	Other	Other	###	26	.	.	.	.	_	15	punct	_	_

